We have a clear commitment: putting best-possible solutions in the hands of medical professionals, enabling them to find the right answer to the challenge they face. Fresenius Kabi is a driver of healthcare for the coming decade. We truly live diversity and value different backgrounds and motivations....+ ←
Bad Homburg / Hessen · Permanent · Full-time · As of now
In this role you will drive the CAPEX planning for TechOps including all production units worldwide, ensuring investment expenditures meet financial goals. You will oversee and track the approval process for investment projects, ensuring timely compliance with guidelines and procedures.
Share this job
Print this Page
Your contact
Nina Reichl
Fresenius Kabi Deutschland GmbH
Bad Homburg (EK2)
Kennziffer R-10011166
Job category:
Finance
Working condition:
Full-time
Business segment:
Fresenius Kabi
Location:
Bad Homburg / Hessen
Closing date for application:
none – We are looking forward to your application
More information
Information about the application process
Our offer at a glance
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients.
fresenius-kabi.com
We seek talents and perspectives
At Fresenius, we are convinced that combining different perspectives, opinions, experiences, cultures and values enables us to harness the potential that will make us even more successful. All job applicants are welcome.
All terms used in this job advertisement to denote persons refer to all genders equally.
Fresenius – Committed to life!
We save and improve human lives with affordable, accessible, and innovative healthcare products and the highest quality in clinical care. Our company comprises the operating business segments Fresenius Kabi and Fresenius Helios. With 140 hospitals and numerous outpatient facilities, Fresenius Helios is the leading private hospital operator in Germany and Spain, treating around 26 million patients each year. Fresenius Kabi's product portfolio includes a range of highly complex biopharmaceuticals, clinical nutrition, medical devices and generic intravenous drugs, serving 450 million people annually.